Natco Pharma Board to Meet Aug 14 for Fund Raising Approval

Natco Pharma Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item is to consider and approve proposals for raising capital. The company is exploring various methods for fund issuance, including equity shares or other securities, through mechanisms such as public issues, preferential issues, rights issues, private placements, qualified institutions placements, or any combination thereof. The decision is subject to market conditions and necessary regulatory, statutory, and other approvals.